[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340366-105":59,"doc-detail-340366-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","photobiomodulation-therapy-to-prevent-oral-mucositis-and-functional-impairment-in-adult-patients-with-haematological-cancer-undergoing-haematopoietic-stem-cell-transplantation-randomised-trial-protocol","Photobiomodulation therapy to prevent oral mucositis and functional impairment in adult patients with haematological cancer undergoing haematopoietic stem cell transplantation - randomised trial protocol","","A randomized trial protocol evaluates photobiomodulation therapy in the oral cavity to prevent oral mucositis and functional impairment in adults undergoing haematopoietic stem cell transplantation for haematological malignancies. The assessor- and statistician-blinded, parallel-group design compares photobiomodulation with control. Thirty participants (18–65) are followed from conditioning through day 20, with daily WHO grading of mucositis and functional capacity measured by step test, Jamar handgrip strength, sit-to-stand, and quality of life questionnaires, plus adherence and acceptability.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/photobiomodulation-therapy-to-prevent-oral-mucositis-and-functional-impairment-in-adult-patients-with-haematological-cancer-undergoing-haematopoietic-stem-cell-transplantation-randomised-trial-protocol/340366/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/photobiomodulation-therapy-to-prevent-oral-mucositis-and-functional-impairment-in-adult-patients-with-haematological-cancer-undergoing-haematopoietic-stem-cell-transplantation-randomised-trial-protocol/340366.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the trial address for adult HSCT patients?","Question",{"text":112,"@type":113},"The trial targets prevention of oral mucositis, which can delay recovery and increase infection risk and functional impairment during haematopoietic stem cell transplantation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is oral mucositis measured in the trial?",{"text":117,"@type":113},"Oral mucositis is assessed daily using the WHO grading scale from the day of transplant through day 20 post-transplant.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes are used to evaluate functional impact and quality of life?",{"text":121,"@type":113},"Functional capacity is evaluated using a 2 min step test, Jamar handgrip strength, and a 30’ sit-to-stand test, and quality of life is measured with the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation Questionnaire.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340366,1790507029,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Open access Protocol  \n Photobiomodulation therapy to prevent  \noral mucositis and functional impairment in adult patients with haematological cancer undergoing haematopoietic stem cell transplantation: randomised trial protocol  \nTomas López-Espinoza,1,2 Cinara Sacomori  ,1 Paulina Araya-Castro,1 Daiana Quintiliano-Scarpelli,1 Paola Roldán,2 Mónica Peña-Espinoza,2 Laura Ferreira de Rezende,3 Hernán López-Vidal2  \nTo cite: López-Espinoza T, Sacomori C, Araya-Castro P, et al. Photobiomodulation therapy to prevent oral mucositis and functional impairment in adult patients with haematological cancer undergoing haematopoietic stem cell transplantation: randomised trial protocol. BMJ Open 2024;14:e088073 . doi:10 . 1136/ bmjopen-2024-088073  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[bmjopen-2024-088073](bmjopen-2024-088073)) .  \nReceived 26 April 2024  \nAccepted 16 September 2024  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nProfessor Cinara Sacomori; [csacomori@yahoo.com.br](csacomori@yahoo.com.br)  \nABSTRACT  \nIntroduction Oral mucositis is a highly prevalent condition in individuals treated for haematological neoplasms, primarily during haematopoietic stem cell transplantation (HSCT) . The condition is known to delay recovery processes, increasing the risk of infection, the number of interventions and the length of hospital stays. The proposed Photobiomodulation Therapy for Oral Mucositis and Functional Impairment Transplantation Trial aims to assess the effectiveness and acceptability of using photobiomodulation in the oral cavity to prevent oral mucositis and functional impairment in adult patients undergoing HSCT.  \nMethods and analysis This is an assessor-blinded and statistician-blinded, parallel-group randomised controlled clinical trial (photobiomodulation vs control group) . Participants and setting: 30 patients, aged 18–65 years, with haematological neoplasms undergoing HSCT at the Clínica Dávila Oncology and Bone Marrow Transplant Unit. Primary outcome measures: oral mucositis will be assessed daily using the WHO grading scale, beginning on the day of transplant through day 20 post-transplant. Researchers will assess functional capacity using a  \n2 min step test, handgrip strength with the Jamar digital dynamometer, lower limb strength using a 30’ sit-to-stand test and quality of life with the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation Questionnaire. Acceptability will be assessed by logging treatment adherence and using a Visual Analogue Scale. Assessments will occur at two time points (1):  \non admission to the transplant unit, before starting the conditioning regimen and (2) on the day of discharge. Intervention: three times per week photobiomodulation therapy using a diode laser device will begin the first day of conditioning and continue through day 3 posttransplant.  \nEthics and dissemination The Clínica Dávila and Universidad del Desarrollo Clinical Research Ethics  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ One strength of this trial is its assessment of physical function outcomes (handgrip strength, functional capacity, physical fitness) in patients undergoing stem cell transplantation who received (or did not receive) photobiomodulation preventive treatment.  \n⇒ Another strength is the measurement of the acceptability of photobiomodulation therapy during haematopoietic stem cell transplantation.  \n⇒ One limitation of the study is the short follow-up, which is up to the day of hospital discharge when patients no longer exhibit oral mucositis.  \n⇒ Another limitation is the impossibility of blinding patients and therapists consid","cbCaiguGnOTLfR4N","https://ap.wps.com/l/cbCaiguGnOTLfR4N","pdf",1077953,"English","# Abstract\n## Introduction\n## Methods and analysis\n## Ethics and dissemination\n## Strengths and limitations\n# Introduction","[{\"question\":\"What problem does the trial address for adult HSCT patients?\",\"answer\":\"The trial targets prevention of oral mucositis, which can delay recovery and increase infection risk and functional impairment during haematopoietic stem cell transplantation.\"},{\"question\":\"How is oral mucositis measured in the trial?\",\"answer\":\"Oral mucositis is assessed daily using the WHO grading scale from the day of transplant through day 20 post-transplant.\"},{\"question\":\"What outcomes are used to evaluate functional impact and quality of life?\",\"answer\":\"Functional capacity is evaluated using a 2 min step test, Jamar handgrip strength, and a 30’ sit-to-stand test, and quality of life is measured with the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation Questionnaire.\"}]","Photobiomodulation therapy to prevent oral mucositis and functional impairment in adult patients with haematological cancer undergoing haematopoietic stem cell transplantation - randomised trial protocol | PDF",1790036078,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ecc462683195ffa87a8b62abdf719fb2.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b851681163d8a15cfb215f65cc5ce313.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32d58a5b6e6e579ecf602bc398d72cb8.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10e23502ccec0593cdb6c328d091d8d0.webp",980,1306]